BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21903242)

  • 21. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
    Iakhiaev AV; Rezaie AR; Idell S
    Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Circulating lupus-type anticoagulant, a risk factor for thrombosis by inhibition of protein C activation].
    Cariou R; Tobelem G; Caen J
    C R Acad Sci III; 1986; 303(4):113-8. PubMed ID: 3019490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protein C pathway.
    Esmon CT
    Chest; 2003 Sep; 124(3 Suppl):26S-32S. PubMed ID: 12970121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The endothelial protein C receptor.
    Esmon CT
    Curr Opin Hematol; 2006 Sep; 13(5):382-5. PubMed ID: 16888445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited abnormalities in the protein C activation pathway.
    España F; Medina P; Navarro S; Estellés A; Aznar J
    Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
    Dahlbäck B; Villoutreix BO
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
    Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
    Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm.
    D'Alessio S; Genua M; Vetrano S
    Ann N Y Acad Sci; 2012 Jul; 1258():78-85. PubMed ID: 22731719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anticoagulant protein C pathway.
    Dahlbäck B; Villoutreix BO
    FEBS Lett; 2005 Jun; 579(15):3310-6. PubMed ID: 15943976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between endothelial cell protein C receptor gene 6936A/G polymorphisms and deep venous thrombosis.
    Chen XD; Tian L; Li M; Jin W; Zhang HK; Zheng CF
    Chin Med J (Engl); 2011 Jan; 124(1):72-5. PubMed ID: 21362311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries.
    Ye X; Fukudome K; Tsuneyoshi N; Satoh T; Tokunaga O; Sugawara K; Mizokami H; Kimoto M
    Biochem Biophys Res Commun; 1999 Jun; 259(3):671-7. PubMed ID: 10364477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endothelial cells and vascular hemostasis].
    Levin EG; Hanano M
    Nihon Rinsho; 1992 Feb; 50(2):303-6. PubMed ID: 1319512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Xuebijing injection on expression of endothelial protein C receptor and protease activated receptor 1 mRNA and protein in endothelial cells induced by lipopolysaccharide].
    Zheng GJ; Wu ZX; Li YP; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):175-8. PubMed ID: 19278590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA; Settas L; Makris PE; Marbet GA
    J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1990; 42(1):54-62. PubMed ID: 2173090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis.
    Anastasiou G; Gialeraki A; Merkouri E; Politou M; Travlou A
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):1-10. PubMed ID: 22036808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway.
    Woodley-Cook J; Shin LY; Swystun L; Caruso S; Beaudin S; Liaw PC
    Mol Cancer Ther; 2006 Dec; 5(12):3303-11. PubMed ID: 17172434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of protein C in congenital and acquired thrombotic disorders.
    Housholder GT
    J Oral Maxillofac Surg; 1988 Sep; 46(9):781-7. PubMed ID: 2842484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality.
    Gu JM; Crawley JT; Ferrell G; Zhang F; Li W; Esmon NL; Esmon CT
    J Biol Chem; 2002 Nov; 277(45):43335-43. PubMed ID: 12218060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.